首页> 外国专利> PREVENTION AND/OR TREATMENT OF CONTRAST-INDUCED ACUTE KIDNEY INJURY

PREVENTION AND/OR TREATMENT OF CONTRAST-INDUCED ACUTE KIDNEY INJURY

机译:预防和/或治疗对比引起的急性肾损伤

摘要

Methods are provided for preventing, reducing, and/or treating contrast-induced acute kidney injury which include administering an inhibitor of fatty acid oxidation to a patient in need thereof. Also provided are methods involving use of trimetazidine or pharmaceutically acceptable salts thereof for the prevention and/or treatment of contrast-induced acute kidney injury. Methods are also provided for preventing and/or treating contrast-induced acute kidney injury which include administration of one or more of trimetazidine, etomoxir, oxfenicine, perhexiline, mildronate, or ranolazine, or pharmaceutically acceptable salts of any of the preceding.
机译:提供了用于预防,减少和/或治疗对比诱导的急性肾损伤的方法,其包括向有此需要的患者施用脂肪酸氧化的抑制剂。 还提供了涉及使用三种嗪或药学上可接受的盐的方法,用于预防和/或治疗对比诱导的急性肾损伤。 还提供了用于预防和/或治疗对比诱导的急性肾损伤的方法,包括给予三种氮杂嗪,戊唑,氧化胺,Perhexiline,淡醌或牛唑啉的一种或多种,或前述任一项的药学上可接受的盐。

著录项

  • 公开/公告号US2021401832A1

    专利类型

  • 公开/公告日2021-12-30

    原文格式PDF

  • 申请/专利权人 SAGHMOS THERAPEUTICS INC.;

    申请/专利号US202117475212

  • 发明设计人 ANNA KAZANCHYAN;SHALINI CORNELIO;

    申请日2021-09-14

  • 分类号A61K31/495;A61P13/12;

  • 国家 US

  • 入库时间 2022-08-24 23:08:24

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号